These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 7666916)

  • 1. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.
    Goldstein AM; Fraser MC; Struewing JP; Hussussian CJ; Ranade K; Zametkin DP; Fontaine LS; Organic SM; Dracopoli NC; Clark WH
    N Engl J Med; 1995 Oct; 333(15):970-4. PubMed ID: 7666916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary cutaneous melanoma.
    Platz A; Ringborg U; Hansson J
    Semin Cancer Biol; 2000 Aug; 10(4):319-26. PubMed ID: 10966854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.
    Hansson J; Bergenmar M; Hofer PA; Lundell G; Månsson-Brahme E; Ringborg U; Synnerstad I; Bratel AT; Wennberg AM; Rosdahl I
    J Clin Oncol; 2007 Jul; 25(19):2819-24. PubMed ID: 17602087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial melanoma, pancreatic cancer and germline CDKN2A mutations.
    Goldstein AM
    Hum Mutat; 2004 Jun; 23(6):630. PubMed ID: 15146471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families.
    Bartsch DK; Langer P; Habbe N; Matthäi E; Chaloupka B; Sina M; Hahn SA; Slater EP
    Clin Genet; 2010 Apr; 77(4):333-41. PubMed ID: 20041885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic carcinoma surveillance in patients with familial melanoma.
    Parker JF; Florell SR; Alexander A; DiSario JA; Shami PJ; Leachman SA
    Arch Dermatol; 2003 Aug; 139(8):1019-25. PubMed ID: 12925390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple primary melanoma revisited.
    Blackwood MA; Holmes R; Synnestvedt M; Young M; George C; Yang H; Elder DE; Schuchter LM; Guerry D; Ganguly A
    Cancer; 2002 Apr; 94(8):2248-55. PubMed ID: 12001124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.
    Tersmette AC; Petersen GM; Offerhaus GJ; Falatko FC; Brune KA; Goggins M; Rozenblum E; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Clin Cancer Res; 2001 Mar; 7(3):738-44. PubMed ID: 11297271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
    Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
    Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of subsequent primary carcinoma of the pancreas in patients with cutaneous malignant melanoma.
    Schenk M; Severson RK; Pawlish KS
    Cancer; 1998 May; 82(9):1672-6. PubMed ID: 9576287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus.
    Kamb A; Shattuck-Eidens D; Eeles R; Liu Q; Gruis NA; Ding W; Hussey C; Tran T; Miki Y; Weaver-Feldhaus J
    Nat Genet; 1994 Sep; 8(1):23-6. PubMed ID: 7987388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary cancer syndrome diagnosis: molecular genetic clues and cancer control.
    Lynch HT; Fusaro RM; Lynch JF
    Future Oncol; 2007 Apr; 3(2):169-81. PubMed ID: 17381417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi.
    Healy E; Belgaid CE; Takata M; Vahlquist A; Rehman I; Rigby H; Rees JL
    Cancer Res; 1996 Feb; 56(3):589-93. PubMed ID: 8564976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
    Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
    J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial melanoma and pancreatic cancer.
    Wright FA; Thomas RG
    N Engl J Med; 1996 Feb; 334(7):470-1; author reply 471-2. PubMed ID: 8552159
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families.
    Goldstein AM; Martinez M; Tucker MA; Demenais F
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):889-94. PubMed ID: 11008905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
    Pho L; Grossman D; Leachman SA
    Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial melanoma and pancreatic cancer. Ligurian Skin Tumor Study Group.
    Ciotti P; Strigini P; Bianchi-Scarrà G
    N Engl J Med; 1996 Feb; 334(7):469-70; author reply 471-2. PubMed ID: 8552158
    [No Abstract]   [Full Text] [Related]  

  • 19. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene.
    Whelan AJ; Bartsch D; Goodfellow PJ
    N Engl J Med; 1995 Oct; 333(15):975-7. PubMed ID: 7666917
    [No Abstract]   [Full Text] [Related]  

  • 20. Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.
    Lal G; Liu L; Hogg D; Lassam NJ; Redston MS; Gallinger S
    Genes Chromosomes Cancer; 2000 Apr; 27(4):358-61. PubMed ID: 10719365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.